ID   BOY-12E
AC   CVCL_7948
SY   BOY
DR   CLO; CLO_0050847
DR   BioSample; SAMN03471926
DR   cancercelllines; CVCL_7948
DR   GEO; GSM492490
DR   Progenetix; CVCL_7948
DR   RCB; RCB2627
DR   TKG; TKG 0641
DR   Wikidata; Q54797961
RX   CelloPub=CLPUB00345;
RX   PubMed=9036862;
RX   PubMed=29732388;
CC   Population: Japanese.
CC   Doubling time: 14.4-25.6 hours (CelloPub=CLPUB00345).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): RCB=RCB2627; TKG=TKG 0641
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 15,17
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
RX   CelloPub=CLPUB00345;
RA   Kayajima T., Shirahama T., Yanase I., Ohi Y.;
RT   "Characterization of a new cell line established from a human
RT   urinary-bladder cancer, with special reference to metastatic ability
RT   to the lung.";
RL   Hinyoki Geka 2:577-580(1989).
//
RX   PubMed=9036862; DOI=10.1002/(SICI)1097-0215(19970220)74:1<7::AID-IJC2>3.0.CO;2-6;
RA   Takemoto M., Shirahama T., Miyauchi T., Matsusako T., Kaneda N.,
RA   Muramatsu H., Ozawa M., Ohi Y., Muramatsu T.;
RT   "Metanestin, a glycoprotein with metastasis-associated expression in
RT   transitional cell carcinoma of the urinary bladder.";
RL   Int. J. Cancer 74:7-14(1997).
//
RX   PubMed=29732388; DOI=10.3233/BLC-180167; PMCID=PMC5929350;
RA   Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.;
RT   "Systematic review: characteristics and preclinical uses of bladder
RT   cancer cell lines.";
RL   Bladder Cancer 4:169-183(2018).
//